Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Anemia 4Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Hematologic Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Transfusion Reaction 1Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Participation 1Myelodysplastic Syndromes 1Multiple Myeloma 1Hemorrhage 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Bone Marrow Failure Disorders 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

Dexamethasone 809Bortezomib 449Lenalidomide 430Cyclophosphamide 336Melphalan 251Calcium Dobesilate 237daratumumab 218pomalidomide 202carfilzomib 181fludarabine phosphate 131Thalidomide 121fludarabine 118Peripheral Blood Stem Cell Transplantation 117Filgrastim 111ixazomib 85Mycophenolic Acid 85Granulocyte Colony-Stimulating Factor 84Busulfan 83Whole-Body Irradiation 80Tacrolimus 75dexamethasone acetate 74Cyclosporine 67isatuximab 64Prednisone 64dexamethasone 21-phosphate 63elotuzumab 60auricularum 57belantamab mafodotin 55Antilymphocyte Serum 55Etoposide 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × Blood Transfusion × Clear all
NCT00578045 2015-10-26

UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies

University of Arkansas

Phase 1 Withdrawn
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡